A NICE transformation?

Pharma Times

1 April 2020 - Will the NICE Review of Methods and Processes pave the way to HTA reform?

Pressure is building in the regulatory arena as advancing biomedical innovation surpasses the methods and processes used in evaluation. 

That pressure has now come to a head with the latest NICE methods review, where the industry is hoping for answers that will deliver a system built for innovation and personalisation. But what can this review reasonably achieve?

Read Pharma Times article

Michael Wonder

Posted by:

Michael Wonder